UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | P | Q | R | S | T | V | W | Z
Number of items: 194.

A

Adams, VC; Hunt, JRF; Martinelli, R; Palmer, R; Rook, GAW; Rosa Brunet, L; (2003) Mycobacterium vaccae induces a CD11c+ population that produces regulatory cytokines in the lungs of allergic mice. In: Immunology. (pp. 50 - 50).

Akter, P; Cunningham, C; McSharry, BP; Dolan, A; Addison, C; Dargan, DJ; ... Davison, AJ; + view all (2003) Two novel spliced genes in human cytomegalovirus. J GEN VIROL , 84 1117 - 1122. 10.1099/vir.0.18952-0.

Andrawiss, M; Takeuchi, Y; Hewlett, L; Collins, M; (2003) Murine leukemia virus particle assembly quantitated by fluorescence microscopy: Role of Gag-Gag interactions and membrane association. J VIROL , 77 (21) 11651 - 11660. 10.1128/JVI.77.21.11651-11660.2003.

B

Balogun, MA; Laurichesse, H; Ramsay, ME; Sellwood, J; Westmoreland, D; Paver, WK; ... PILLAY, D; + view all (2003) Risk factors, clinical features and genotype distribution of diagnosed hepatitis C virus infections: a pilot for a sentinel laboratory-based surveillance. Communicable Disease and Public Health , 6 (1) 34 - 39.

Barrett-Muir, W; Scott, FT; Aaby, P; John, J; Matondo, P; Chaudhry, QL; ... Breuer, J; + view all (2003) Genetic variation of varicella-zoster virus: evidence for geographical separation of strains. J Med Virol , 70 Suppl 1 S42 - S47. 10.1002/jmv.10319.

Barry, SM; Johnson, MA; Janossy, G; (2003) Increased proportions of activated and proliferating memory CD8+ T cell lymphocytes in both blood and lungs are associated with HIV viral load. In: Journal of Acquired Immunodeficiency Syndromes. (pp. 351 - 357).

Barry, SM; Lipman, MC; Bannister, B; Johnson, MA; Janossy, G; (2003) Purified protein derivative-activated type 1 cytokine-producing CD4+ T lymphocytes in the lung: a characteristic feature of active pulmonary and nonpulmonary tuberculosis. J Infect Dis , 187 (2) 243 - 250. 10.1086/346112.

Batt, SL; Charalambous, BM; Solomon, AW; Knirsch, C; Massae, PA; Safari, S; ... Gillespie, SH; + view all (2003) Impact of azithromycin administration for trachoma control on the carriage of antibiotic-resistant Streptococcus pneumoniae. ANTIMICROB AGENTS CH , 47 (9) 2765 - 2769. 10.1128/AAC.47.9.2765-2769.2003.

Berthoux, L; Towers, GJ; Gurer, C; Salomoni, P; Pandolfi, PP; Luban, J; (2003) As2O3 enhances retroviral reverse transcription and counteracts Ref1 antiviral activity. J VIROL , 77 (5) 3167 - 3180. 10.1128/JVI.77.5.3167-3180.2003.

Besnier, C; Ylinen, L; Strange, B; Lister, A; Takeuchi, Y; Goff, SP; Towers, GJ; (2003) Characterization of murine leukemia virus restriction in mammals. J VIROL , 77 (24) 13403 - 13406. 10.1128/JVI.77.24.13403-13406.2003.

Beyan, H; Buckley, LR; Yousaf, N; Londei, M; Leslie, RD; (2003) A role for innate immunity in type 1 diabetes? Diabetes Metab Res Rev , 19 (2) 89 - 100. 10.1002/dmrr.341.

Breivik, T; Rook, GAW; (2003) Oral treatment with SRP299 (killed Mycobacterium vaccae) inhibits experimental periodontal disease in Wistar rats. J CLIN PERIODONTOL , 30 (11) 931 - 936.

Breuer, J; (2003) Commentary on Herpes zoster guidelines of the German Dermatological Society. J CLIN VIROL , 26 (3) 291 - 293. 10.1016/S1386-6532(03)00032-5.

Breuer, J; (2003) Live attenuated vaccine for the prevention of varicella-zoster virus infection: does it work, is it safe and do we really need it in the UK? J MED MICROBIOL , 52 (1) 1 - 3. 10.1009/jmm.0.05073-0.

Breuer, J; (2003) Monitoring virus strain variation following infection with VZV: is there a need and what are the implications of introducing the Oka vaccine? Commun Dis Public Health , 6 (1) 59 - 62.

Bunyard, P; Handley, M; Pollara, G; Rutault, K; Wood, I; Chaudry, M; ... Chain, BM; + view all (2003) Ribotoxic stress activates p38 and JNK kinases and modulates the antigen-presenting activity of dendritic cells. MOL IMMUNOL , 39 (13) 815 - 827.

C

Cairns, TM; Milne, RSB; Ponce-De-Leon, M; Tobin, DK; Cohen, GH; Eisenberg, RJ; (2003) Structure-function analysis of herpes simplex virus type 1 gD and gH-gL: Clues from gDgH chimeras. J VIROL , 77 (12) 6731 - 6742. 10.1128/JVI.77.12.6731-6742.2003.

Camporota, L; Corkhill, A; Long, H; Lordan, J; Stanciu, L; Tuckwell, N; ... Djukanovic, R; + view all (2003) The effects of Mycobacterium vaccae on allergen-induced airway responses in atopic asthma. EUR RESPIR J , 21 (2) 287 - 293. 10.1183/09031936.03.00042103.

Casburn-Jones, AC; Sabin, C; Maybin, S; Zuckerman, JN; (2003) Retrospective longitudinal study on gastrointestinal morbidity in VSO volunteers working abroad. In: GUT. (pp. A100 - A101). BRITISH MED JOURNAL PUBL GROUP

Cathcart, S; Boyle, J; Sabin, CA; Johnson, MA; Zuckerman, JN; (2003) Pre-travel preparation and outcome of HIV-infected travellers from a UK clinic. Travel Medicine and Infectious Disease , 1 (2) 114 - 118. 10.1016/S1477-8939(03)00024-3.

Cepeda, J; Hayman, S; Whitehouse, T; Kibbler, CC; Livermore, D; Singer, M; Wilson, AP; (2003) Teicoplanin resistance in methicillin-resistant Staphylococcus aureus in an intensive care unit. J Antimicrob Chemother , 52 (3) 533 - 534. 10.1093/jac/dkg369.

Cepeda, J; Hayman, S; Whitehouse, T; Kibbler, CC; Livermore, D; Singer, M; Wilson, APR; (2003) Teicoplanin resistance in methicillin-resistant Staphylococcus aureus in an intensive care unit. J ANTIMICROB CHEMOTH , 52 (3) 533 - 534. 10.1093/jac/dkg369.

Cepeda, JA; Whitehouse, T; Cooper, B; Hails, J; Jones, K; Kwaku, F; ... Wilson, APR; + view all (2003) Source isolation in intensive care units does not reduce spread of MRSA beyond that achieved by universal precautions: a prospective two-centre study. In: (Proceedings) 13th European Congress of Clinical Microbiology and Infectious Diseases. : Glasgow.

Chakrabarti, S; Milligan, DW; Pillay, D; Mackinnon, S; Holder, K; Kaur, N; ... Steven, N; + view all (2003) Reconstitution of the Epstein-Barr virus-specific cytotoxic T-lymphocyte response following T-cell-depleted myeloablative and nonmyeloablative allogeneic stem cell transplantation. BLOOD , 102 (3) 839 - 842.

Charalambous, BM; Batt, SL; Peek, AC; Mwerinde, H; Sam, N; Gillespie, SH; (2003) Quantitative validation of media for transportation and storage of Streptococcus pneumoniae. J CLIN MICROBIOL , 41 (12) 5551 - 5556. 10.1128/JCM.41.12.5551-5551-2003.

Clark, DA; Emery, VC; Griffiths, PD; (2003) Cytomegalovirus, human herpesvirus-6, and human herpesvirus-7 in hematological patients. SEMIN HEMATOL , 40 (2) 154 - 162. 10.1053/shem.2003.50015.

Clark, DA; Fryer, JFL; Tucker, AW; McArdle, PD; Hughes, AE; Emery, VC; Griffiths, PD; (2003) Porcine cytomegalovirus in pigs being bred for xenograft organs: progress towards control. XENOTRANSPLANTATION , 10 (2) 142 - 148.

Clark, DA; Griffiths, PD; (2003) Human herpesvirus 6: Relevance of infection in the immunocompromised host. BRIT J HAEMATOL , 120 (3) 384 - 395.

Cook, GC; Zumla, A; (2003) Cutaneous Viral Disease. In: Cook, GC and Zumla, AI, (eds.) Manson's Tropical Diseases. (841 - 859). W.B. Saunders, Elsevier Science Ltd: Edinburgh.

Cooper, BS; Stone, SP; Kibbler, CC; Cookson, BD; Roberts, JA; Medley, GF; ... Ebrahim, S; + view all (2003) Systematic review of isolation policies in the hospital management of methicillin-resistant Staphylococcus aureus: a review of the literature with epidemiological and economic modelling. Health Technol Assess , 7 (39) 1 - 194.

Corden, S; Ballard, AL; Ijaz, S; Barbara, JAJ; Gilbert, N; Gilson, RJC; ... Tedder, RS; + view all (2003) HBV DNA levels and transmission of hepatitis B by health care workers. J CLIN VIROL , 27 (1) 52 - 58.

Corona, A; Bertolini, G; Ricotta, AM; Wilson, AJP; Singer, M; (2003) Variability of treatment duration for bacteraemia in the critically ill: a multinational survey. J ANTIMICROB CHEMOTH , 52 (5) 849 - 852. 10.1093/jac/dkg447.

D

Dai, L; Claxson, A; Marklund, SL; Feakins, R; Yousaf, N; Chernajovsky, Y; Winyard, PG; (2003) Amelioration of antigen-induced arthritis in rats by transfer of extracellular superoxide dismutase and catalase genes. Gene Ther , 10 (7) 550 - 558. 10.1038/sj.gt.3301916.

Dale, JW; Al-Ghusein, H; Al-Hashmi, S; Butcher, P; Dickens, AL; Drobniewski, F; ... Yesilkaya, H; + view all (2003) Evolutionary relationships among strains of Mycobacterium tuberculosis with few copies of IS6110. J BACTERIOL , 185 (8) 2555 - 2562. 10.1128/JB.185.8.2555-2562.2003.

Davison, AJ; Akter, P; Cunningham, C; Dolan, A; Addison, C; Dargan, DJ; ... Wilkinson, GWG; + view all (2003) Homology between the human cytomegalovirus PL11 gene family and human adenovirus E3 genes. J GEN VIROL , 84 657 - 663. 10.1099/vir.0.18856-0.

Denning, DW; Kibbler, CC; Barnes, RA; (2003) Standards of care for invasive fungal infections. The Lancet Infectious Diseases , 3 (4) 230 - 240. 10.1016/S1473-3099(03)00580-2.

Denning, DW; Kibbler, CC; Barnes, RA; (2003) Standards of care for invasive fungal infections - Authors' reply. LANCET INFECT DIS , 3 (7) 402 - 403.

Denning, DW; Kibbler, CC; Barnes, RA; Brit Soc Medical Mycology,; (2003) British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections. LANCET INFECT DIS , 3 (4) 230 - 240.

Dervisevic, S; PILLAY, D; (2003) Issues in diagnostic testing and monitoring in HIV/viral hepatitis co-infection. Journal of HIV Therapy , 8 (4) 89 - 95.

E

Ericsson, TA; Takeuchi, Y; Templin, C; Quinn, G; Farhadian, SF; Wood, JC; ... Patience, C; + view all (2003) Identification of receptors for pig endogenous retrovirus. P NATL ACAD SCI USA , 100 (11) 6759 - 6764. 10.1073/pnas.1138025100.

F

Fassati, A; Gorlich, D; Harrison, I; Zaytseva, L; Mingot, JM; (2003) Nuclear import of HIV-1 intracellular reverse transcription complexes is mediated by importin 7. EMBO J , 22 (14) 3675 - 3685.

Fryer, J; Emery, V; Griffiths, P; Clark, D; (2003) Susceptibility of porcine cytomegalovirus to antiviral drugs. In: XENOTRANSPLANTATION. (pp. 520 - 520). BLACKWELL MUNKSGAARD

G

Gandy, M; Zumla, A; (2003) The Return of the White Plague: Global Poverty and the 'New' Tuberculosis. Verso: London and New York.

Gandy, M; Zumla, A; (2003) Introduction. In: Gandy, M and Zumla, A, (eds.) The return of the white plague: global poverty and the 'new' tuberculosis. (7 - 12). Verso: London.

Garson, JA; (2003) Commentary on J Clausen's review--endogenous retroviruses in MS. Int MS J , 10 (1) 20 - 21.

Garson, JA; (2003) Endogenous retrovirusesin MS. International MS Journal , 10 (1) 20 - 21. Green open access
file

Gent, AM; Zuckerman, JN; (2003) A review of the Infection Control Policies for Blood Borne Viruses as applied to Non Governmental Organisations’ (NGOs). Journal of Travel Medicine & Infectious Disease , 1 29 - 33.

Gilleece, Y; Torti, C; Mandalia, S; Gazzard, BG; PILLAY, D; Pozniak, AL; (2003) The prevalence of reduced zidovudine susceptibility in zidovudine-naive, antiretroviral-experienced HIV-1-infected patients. HIV Medicine , 4 (4) 305 - 310.

Gillespie, S; (2003) Salmonella Infections. In: Cook, GC, (ed.) Manson's Tropical Diseases. (937 - 949). W.B. Saunders, Elsevier Science Ltd: Edinburgh.

Gillespie, S; McLachlan, M; Shrimpton, R; (2003) Combating Malnutrition: time to act. The World Bank: Washington DC.

Gillespie, SH; (2003) Treatment of skin infections. Prescriber

Gillespie, SH; (2003) Migrating Worms. In: Cohen, J and Powderly, WG, (eds.) Infectious Diseases. Mosby: Edinburgh.

Gillespie, SH; Bamford, KB; (2003) Medical Microbiology and Infection at a Glance. (2nd ed.). Blackwell Science: Oxford.

Gillespie, SH; Charalambous, BM; (2003) A novel method for evaluating the antimicrobial activity of tuberculosis treatment regimens. INT J TUBERC LUNG D , 7 (7) 684 - 689.

Gillespie, SH; Charalambous, BM; Gosling, RD; (2003) A reiterative method for calculating bactericidal activity. AM J RESP CRIT CARE , 167 (4) 664 - 664.

Gillespie, SH; Gosling, RD; Charalambous, BM; (2003) Bactericidal activity of antituberculosis drugs. AM J RESP CRIT CARE , 167 (4) 663 - 663.

Gillespie, SH; McHugh, TD; (2003) Criteria for identification of cross-contamination of cultures of Mycobacterium tuberculosis in routine microbiology laboratories (letter). Journal of Clinical Microbiology , 41 (5) 2269 - 2270.

Gillespie, SH; McHugh, TD; (2003) Criteria for identification of cross-contamination of cultures of Mycobacterium tuberculosis in routine microbiology laboratories - Authors' reply (reference 4). J CLIN MICROBIOL , 41 (5) 2269 - 2270.

Gillespie, SH; Voelker, LL; Ambler, JE; Traini, C; Dickens, A; (2003) Fluoroquinolone resistance in Streptococcus pneumoniae: Evidence that gyrA mutations arise at a lower rate and that mutation in gyrA or parC predisposes to further mutation. MICROB DRUG RESIST , 9 (1) 17 - 24.

Gnanalingham, KK; Elsaghier, A; Kibbler, C; Shieff, C; (2003) The impact of methicillin-resistant Staphylococcus aureus in a neurosurgical unit: a growing problem. J Neurosurg , 98 (1) 8 - 13. 10.3171/jns.2003.98.1.0008.

Goldberg, NR; Beuming, T; Soyer, OS; Goldstein, RA; Weinstein, H; Javitch, JA; (2003) Probing conformational changes in neurotransmitter transporters: a structural context. EUROPEAN JOURNAL OF PHARMACOLOGY , 479 (1-3) 3 - 12. 10.1016/j.ejphar.2003.08.052.

Goldstein, RA; (2003) Evolutionary perspectives on protein folding, structure, and thermodynamics. In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. (pp. U282 - U282).

Gosling, RD; Heifets, L; Gillespie, SH; (2003) A multicentre comparison of a novel surrogate marker for determining the specific potency of anti-tuberculosis drugs. J ANTIMICROB CHEMOTH , 52 (3) 473 - 476. 10.1093/jac/dkg345.

Gosling, RD; Uiso, LO; Sam, NE; Bongard, E; Kanduma, EG; Nyindo, M; ... Gillespie, SH; + view all (2003) The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis. AM J RESP CRIT CARE , 168 (11) 1342 - 1345. 10.1164/rccm.200305-682OC. Green open access
file

Grahame-Clarke, C; Chan, NN; Andrew, D; Ridgway, GL; Betteridge, DJ; Emery, V; ... Vallance, P; + view all (2003) Human cytomegalovirus seropositivity is associated with impaired vascular function. Circulation , 108 (6) 678 - 683.

Grahame-Clarke, C; Chan, NN; Andrew, D; Ridgway, GL; Betteridge, DJ; Emery, V; ... Vallance, P; + view all (2003) Human cytomegalovirus seropositivity is associated with impaired vascular function. CIRCULATION , 108 (6) 678 - 683. 10.1161/01.CIR.0000084505.54603.C7.

Grange, JM; Zumla, A; (2003) Anti-tuberculosis agents. In: Cohen, J and Powderly, WG, (eds.) Infectious Diseases. (1851 - 1867). Elsevier Health Sciences: London.

Grange, JM; Zumla, A; (2003) Human Disease due to Environmental Mycobacteria. In: Cook, GC, (ed.) Manson's Tropical Diseases. (1053 - 1064). W.B. Saunders, Elsevier Science Ltd: Edinburgh.

Grange, JM; Zumla, A; (2003) Tuberculosis. In: Cook, GC, (ed.) Manson's Tropical Diseases. (995 - 1052). W.B. Saunders, Elsevier Science Ltd: Edinburgh.

Grant, PR; Chan, PKS; Garson, JA; Sung, JJY; Tam, JS; Tedder, RS; (2003) Quantitative detection of SARS CoV in blood by real-time RT-PCR. In: JOURNAL OF CLINICAL VIROLOGY. (pp. S91 - S91). ELSEVIER SCIENCE BV

Grant, PR; Garson, JA; Tedder, RS; Chan, PKS; Tam, JS; Sung, JJY; (2003) Detection of SARS coronavirus in plasma by real-time RT-PCR. NEW ENGL J MED , 349 (25) 2468 - 2469. Green open access
file

Greber, UF; Fassati, A; (2003) Nuclear import of viral DNA genomes. TRAFFIC , 4 (3) 136 - 143.

Gregorio, GV; Choudhuri, K; Ma, Y; Pensati, P; Iorio, R; Grant, P; ... Vergani, D; + view all (2003) Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection. Clinical and Experimental Immunology , 133 (3) 404 - 413. 10.1046/j.1365-2249.2003.02229.x.

Griffiths, P; (2003) The indirect effects of virus infections. Reviews in Medical Virology , 13 (1) 1 - 3. 10.1002/rmv.385.

Griffiths, PD; (2003) An earlier role for viral pharmacodynamics. Reviews in Medical Virology , 13 (3) 135 - 136. 10.1002/rmv.394.

Griffiths, PD; (2003) Therapeutic patents for cytomegalovirus. EXPERT OPIN THER PAT , 13 (3) 319 - 327.

Gunson, RN; Shouval, D; Roggendorf, M; Zaaijer, H; Nicholas, H; Holzmann, H; ... Grp, EC; + view all (2003) Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients. JOURNAL OF CLINICAL VIROLOGY , 27 (3) 213 - 230. 10.1016/S1386-6532(03)00087-8.

H

Hails, J; Kwaku, F; Wilson, AP; Bellingan, G; Singer, M; (2003) Large variation in MRSA policies, procedures and prevalence in English intensive care units: a questionnaire analysis. INTENS CARE MED , 29 (3) 481 - 483. 10.1007/s00134-003-1645-y.

Hajioff, D; Enever, Y; Quiney, R; Zuckerman, JN; MacDermot, K; Mehta, A; (2003) Hearing loss in Fabry Disease: the effect of agalsidase alfa replacement therapy. Journal of Inherited Metabolic Disease , 26 (8) 787 - 794.

Hajioff, D; Goodwin, S; Quiney, R; Zuckerman, JN; MacDermot, KD; Mehta, A; (2003) Hearing improvement in patients with Fabry disease treated with agalsidase alfa. Acta Paediatrica , 92 (443) 28 - 30.

Harries, AD; Hargreaves, NJ; Zumla, A; (2003) Tuberculosis and HIV infection in sub-Saharan Africa. In: Gandy, M and Zumla, A, (eds.) The return of the white plague: global poverty and the 'new' tuberculosis. (112 - 124). Verso: London.

Hatziioannou, T; Cowan, S; Goff, SP; Bieniasz, PD; Towers, GJ; (2003) Restriction of multiple divergent retroviruses by Lv1 and Ref1. EMBO J , 22 (3) 385 - 394.

Hatziioannou, T.; Cowan, S.; Goff, S.P.; Bieniasz, P.D.; Towers, G.J.; (2003) Restriction of multiple divergent retroviruses by Lv1 and Ref1. The EMBO Journal , 22 (3) pp. 385-394. 10.1093/emboj/cdg042.

Hawkey, PM; Bhagani, S; Gillespie, SH; (2003) Severe acute respiratory syndrome (SARS): breathtaking progress. J MED MICROBIOL , 52 (8) 609 - 613. 10.1099/jmm.0.05321-0. Green open access
file

Huggett, JF; McHugh, TD; Zumla, A; (2003) Tuberculosis: amplification-based clinical diagnostic techniques. INT J BIOCHEM CELL B , 35 (10) 1407 - 1412. 10.1016/S1357-2725(03)00102-X.

I

Ijaz, M; Zumla, A; (2003) Treating AIDS: a new approach. National Review [Online Version] , Availa

Ijaz, S; Ferns, B; Tedder, RS; (2003) A 'first loop' linear epitope accessible on native hepatitis B surface antigen that persists in the face of 'second loop' immune escape. J GEN VIROL , 84 269 - 275. 10.1099/vir.0.18667-0.

Ijaz, S; Ferns, RB; Tedder, RS; (2003) A 'first loop' linear epitope accessible on native hepatitis B surface antigen that persists in the face of 'second loop' immune escape. J Gen Virol , 84 (Pt 2) 269 - 275.

Ijaz, S; Khulan, J; Bissett, S; Ferns, RB; Nymadawa, P; Tedder, RS; (2003) Hepatitis B breakthrough infections in a hyperendemic country. In: JOURNAL OF CLINICAL VIROLOGY. (pp. S82 - S82). ELSEVIER SCIENCE BV

Ikeda, Y; Takeuchi, Y; Martin, F; Cosset, FL; Mitrophanous, K; Collins, M; (2003) Continuous high-titer HIV-1 vector production. NAT BIOTECHNOL , 21 (5) 569 - 572. 10.1038/nbt815.

Isaac, A; PILLAY, D; (2003) New drugs for treating drug resistant HIV-1. Sexually Transmitted Diseases , 79 (3) 176 - 178.

J

Jenner, RG; Maillard, K; Cattini, N; Weiss, RA; Boshoff, C; Wooster, R; Kellam, P; (2003) Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a gene expression profile. P NATL ACAD SCI USA , 100 (18) 10399 - 10404. 10.1073/pnas.1630810100.

Johnson, VA; Brun-Vezinet, F; Clotet, B; Conway, B; D'Aquila, RT; Demeter, LM; ... PILLAY, D; + view all (2003) Drug resistance mutations in HIV-1. Topics in HIV Medicine , 11 (6) 215 - 221.

Jong, EJ; Zuckerman, J; (2003) Travellers’ Vaccines. (1st ed.). BC Decker

K

Kanduma, E; McHugh, TD; Gillespie, SH; (2003) Molecular methods for Mycobacterium tuberculosis strain typing: a users guide. J APPL MICROBIOL , 94 (5) 781 - 791.

Kellam, P; Holzerlandt, R; Jenner, R; Kwan, A; Gramoustianou, E; DeGroot,; (2003) Viral bioinformatics: Computational views of host and pathogen. Novartis Foundation Symposium , 254 234 - 249.

Kellam, P; Liu, X; (2003) Experimental use of DNA arrays. In: Orengo, CA and Jones, DT and Thornton, JM, (eds.) Bioinformatics: gene proteins and computers. BIOS Scientific Publishers Limited

Kerbiriou, L; Ustianowski, A; Johnson, MA; Gillespie, SH; Miller, RF; Lipman, MCI; (2003) Human immunodeficiency virus type 1-related pulmonary Mycobacterium xenopi infection: A need to treat? CLIN INFECT DIS , 37 (9) 1250 - 1254.

Kibbler, C; (2003) Aspergillus: the invisible threat. Nurs Times , 99 (48) 48 - 50.

Kibbler, CC; (2003) Infections Associated with Neutropenia. In: Finch, RG and Greenwood, D and Norrby, SR and Whitley, RJ, (eds.) Antibiotic and Chemotherapy. Churchill Livingstone: Edinburgh.

Kibbler, CC; Mele, A; Paterson, PJ; Prentice, HG; (2003) Response to Martino and Cordonnier. Bone Marrow Transplantation , 31 (7) 619 - 619.

Kibbler, CC; Mele, A; Paterson, PJ; Prentice, HG; (2003) Toxoplasmosis following allogeneic hematopoietic stem cell transplantation - Response to Martino and Cordonnier. BONE MARROW TRANSPL , 31 (7) 619 - 619. 10.1038/sj.bmt.1703915.

Kibbler, CC; Ruddy, M; (2003) Endoscopic decontamination: an audit and practical review. A reply. Journal of Hospital Infection , 54 (1) 84 - 84.

Kibbler, CC; Ruddy, M; (2003) Endoscopic decontamination: an audit and practical review. A reply. J HOSP INFECT , 54 (1) 83 - 83. 10.1016/S0195-6701(03)00036-7.

Kibbler, CC; Seaton, S; Barnes, RA; Gransden, WR; Holliman, RE; Johnson, EM; ... Wilson, JA; + view all (2003) Management and outcome of bloodstream infections due to Candida species in England and Wales. J HOSP INFECT , 54 (1) 18 - 24. 10.1016/S0195-6701(03)00085-9.

Kinloch, S; (2003) The QUEST Trial. “Immune reconstitution & control of HIV”. Presented at: RIGHT, Stresa, Italy.

Kinloch, S; (2003) The role of early treatment for HIV. Presented at: Federation of Infection Societies, Cardiff, UK.

L

Laundy, M; Ajayi-Obe, E; Hawrami, K; Aitken, C; Breuer, J; Booy, R; (2003) Influenza A community-acquired pneumonia in East London infants and young children. PEDIATRIC INFECTIOUS DISEASE JOURNAL , 22 (10) S223 - S227.

Liu, X; Kellam, P; (2003) Mining gene expression data. In: Orengo, C and Jones, T, (eds.) Bioinformatics: genes proteins and computers. BIOS Scientific Publishers Limited

M

Maartens, G; Mwaga, P; Zumla, A; (2003) General Approach to the Patient. In: Cook, GC, (ed.) Manson's Tropical Diseases. (95 - 109). W.B. Saunders, Elsevier Science Ltd: Edinburgh.

Magre, S; Takeuchi, Y; Bartosch, B; (2003) Xenotransplantation and pig endogenous retroviruses. REV MED VIROL , 13 (5) 311 - 329. 10.1002/rmv.404.

Maguire, H; Dale, JW; McHugh, TD; Butcher, PD; Gillespie, SH; Costetsos, A; ... Banerjee, DK; + view all (2003) Molecular epidemiology of tuberculosis in London 1995-7 showing low rate of active transmission. J CLIN PATHOL-MOL PA , 56 (2) 121 - 126.

Manson, SP; Cook, GC; Zumla, A; (2003) Manson's tropical diseases. (21st edition softback version ed.). Saunders Ltd

Manson, SP; Cook, GC; Zumla, A; (2003) Manson's tropical diseases. (21st edition hardback version ed.). Saunders Ltd: USA.

Martinelli, R; Hunt, JRF; Rook, GAW; Rosa Brunet, L; (2003) Effects of Mycobacterium vaccae on peritoneal exudate cells of napve mice. In: Immunology. (pp. 50 - 50).

Mays, SA; Taylor, GM; (2003) A First Prehistoric Case of Tuberculosis from Britain. International Journal of Osteoarchaeology , 13 189 - 196.

McKnight, D; Weiss, RA; (2003) Blocking the docking of HIV-1. P NATL ACAD SCI USA , 100 (19) 10581 - 10582. 10.1073/pnas.2035071100.

Milne, RSB; Hanna, SL; Rux, AH; Willis, SH; Cohen, GH; Eisenberg, RJ; (2003) Function of herpes simplex virus type 1 gD mutants with different receptor-binding affinities in virus entry and fusion. J VIROL , 77 (16) 8962 - 8972. 10.1128/JVI.77.16.8962-8972.2003.

Morgan, E; Pillay, D; Cane, P; Kleim, JP; Tisdale, M; Maguire, M; ... Elston, R; + view all (2003) The HIV-1 protease mutation K55R is associated with the presence of the M461/L mutation. In: ANTIVIRAL THERAPY. (pp. U57 - U58). INT MEDICAL PRESS LTD

Mwaba, P; Cassol, S; Nunn, A; Pilon, R; Chintu, C; Janes, M; Zumla, A; (2003) Whole blood versus plasma spots for measurement of HIV-1 viral load in HIV-infected African patients. LANCET , 362 (9401) 2067 - 2068.

Mwaba, P; Cassol, S; Pilon, R; Chintu, C; Janes, M; Nunn, A; Zumla, A; (2003) Use of dried whole blood spots to measure CD4+lymphocyte counts in HIV-1-infected patients. LANCET , 362 (9394) 1459 - 1460.

Mwaba, P; Maboshe, M; Chintu, C; Squire, B; Nyirenda, S; Sunkutu, R; Zumla, A; (2003) The relentless spread of tuberculosis in Zambia - trends over the past 37 years (1964-2000). SAMJ S AFR MED J , 93 (2) 149 - 152. Gold open access

N

Nelson, M; Portsmouth, S; Stebbing, J; Atkins, M; Barr, A; Matthews, G; ... Gazzard, B; + view all (2003) An open-label study of tenofovir in HIV-1 and Hepatitis B virus co-infected individuals. AIDS , 17 (1) F7 - 10.

Nermut, MV; Fassati, A; (2003) Structural analyses of purified human immunodeficiency virus type 1 intracellular reverse transcription complexes. J VIROL , 77 (15) 8196 - 8206. 10.1128/JVI.77.15.8196-8206.2003.

Newton, R; Ziegler, J; Bourboulia, D; Casabonne, D; Beral, V; Mbidde, E; ... Boshoff, C; + view all (2003) Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda. British Journal of Cancer , 89 (3) 502 - 504.

Newton, R; Ziegler, J; Bourboulia, D; Casaborne, D; Beral, V; Mbidde, E; ... Boshoff, C; + view all (2003) The sero-epidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in adults with cancer in Uganda. International Journal of Cancer , 103 (2) 226 - 232.

Nothdurft, HD; Dietrich, M; Zuckerman, JN; Knobloch, J; Kern, P; Sanger, R; (2003) Rapid protection against hepatitis A and B using an accelerated vaccination schedule - Comparison of combined vaccine, Twinrix (R), with separate vaccines. BIODRUGS , 17 15 - 18.

Nothdurft, HD; Dietrich, M; Zuckerman, JNK; J, K; P, S; R,; (2003) Rapid protection against Hepatitis A and B using an accelerated vaccination schedule; comparison of combined vaccine, Twinrix, with separate vaccines. BioDrugs , 17 15 - 18.

P

Paterson, PJ; Seaton, S; McLaughlin, J; Kibbler, CC; (2003) Development of molecular methods for the identification of aspergillus and emerging moulds in paraffin wax embedded tissue sections. J CLIN PATHOL-MOL PA , 56 (6) 368 - 370.

Paterson, PJ; Seaton, S; Prentice, HG; Kibbler, CC; (2003) Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B. J ANTIMICROB CHEMOTH , 52 (5) 873 - 876. 10.1093/jac/dkg434.

Philpott-Howard, J; Burroughs, A; Fisher, N; Hastings, M; Kibbler, C; Mutimer, D; ... O'Grady, J; + view all (2003) Piperacillin-tazobactam versus ciprofloxacin plus amoxicillin in the treatment of infective episodes after liver transplantation. J ANTIMICROB CHEMOTH , 52 (6) 993 - 1000. 10.1093/jac/dkg463.

Pillay, D; Green, H; UK Collaborative Grp HIV Drug Resi,; (2003) The UKHIV Drug Resistance Database: development and use for national surveillance. In: ANTIVIRAL THERAPY. (pp. U120 - U120). INT MEDICAL PRESS LTD

Pollara, G; Speidel, K; Samady, L; Rajpopat, M; McGrath, Y; Ledermann, J; ... Chain, B; + view all (2003) Herpes simplex virus infection of dendritic cells: Balance among activation, inhibition, and immunity. J INFECT DIS , 187 (2) 165 - 178.

Preiser, W; Brink, NS; Ayliffe, U; Peggs, KS; Mackinnon, S; Tedder, RS; Garson, JA; (2003) Development and clinical application of a fully controlled quantitative PCR assay for cell-free cytomegalovirus in human plasma. J CLIN VIROL , 26 (1) 49 - 59.

Q

Qian, B; Goldstein, RA; (2003) Detecting distant homologs using phylogenetic tree-based HMMs. Proteins , 52 (3) 446 - 453. 10.1002/prot.10373.

Qian, B; Soyer, OS; Neubig, RR; Goldstein, RA; (2003) Depicting a protein's two faces: GPCR classification by phylogenetic tree-based HMMs. FEBS Lett , 554 (1-2) 95 - 99.

R

Rad, AN; Pollara, G; Sohaib, SMA; Chiang, C; Chain, BM; Katz, DR; (2003) The differential influence of allogeneic tumor cell death via DNA damage on dendritic cell maturation and antigen presentation. CANCER RES , 63 (16) 5143 - 5150.

Raisch, KP; Pizzato, M; Sun, HY; Takeuchi, Y; Cashdollar, LW; Grossberg, SE; (2003) Molecular cloning, complete sequence, and biological characterization of a xenotropic murine leukemia virus constitutively released from the human B-lymphoblastoid cell line DG-75. VIROLOGY , 308 (1) 83 - 91. 10.1016/S0042-6822(02)00074-0.

Relander, T; Johansson, M; Olsson, K; Ikeda, Y; Takeuchi, Y; Collins, M; Richter, J; (2003) Gene transfer to repopulating human CD34+cells using amphotropic or RD114 pseudotyped HIV-1 based vectors from permanent producer cell lines (STAR). In: BLOOD. (pp. 991A - 991A). AMER SOC HEMATOLOGY

Rook, GA; Martinelli, R; Brunet, LR; (2003) Innate immune responses to mycobacteria and the downregulation of atopic responses. Curr Opin Allergy Clin Immunol , 3 (5) 337 - 342. 10.1097/01.all.0000092602.76804.ad.

S

Sabin, CA; Wilkins, E; Murphy, M; Fisher, M; de Ruiter, A; Easterbrook, PJ; ... UK Expanded Access Amprenavir Prog,; + view all (2003) Drug resistance genotypes predict response to amprenavir-containing regimens in highly drug-experienced HIV-1-infected patients. ANTIVIR THER , 8 (4) 301 - 308.

Scott, FT; Leedham-Green, ME; Barrett-Muir, WY; Hawrami, K; Gallagher, WJ; Johnson, R; Breuer, J; (2003) A study of shingles and the development of postherpetic neuralgia in East London. J Med Virol , 70 Suppl 1 S24 - S30. 10.1002/jmv.10316.

Smith, CJ; Sabin, CA; Lampe, FC; Kinloch-de-Loes, S; Gumley, H; Carroll, A; ... Phillips, AN; + view all (2003) The potential for CD4 cell increases in HIV-positive individuals who control viraemia with highly active antiretroviral therapy. AIDS , 17 (7) 963 - 969. 10.1097/01.aids.0000060352.78202.79.

Soyer, OS; Dimmic, MW; Neubig, RR; Goldstein, RA; (2003) Dimerization in aminergic G-protein-coupled receptors: application of a hidden-site class model of evolution. Biochemistry , 42 (49) 14522 - 14531. 10.1021/bi035097r.

Steffen, R; Acar, J; Walker, E; Zuckerman, JN; (2003) Cholera: Assessing the risk to travellers and identifying methods of protection. Journal of Travel Medicine & Infectious Disease , 1 80 - 88.

T

Tanuri, A; Soares, MA; Dumans, AT; Hue, S; Pillay, D; (2003) Synonomous genetic changes within subtype FHIV-1 may influence mutational routes to drug resistance. In: ANTIVIRAL THERAPY. (pp. U122 - U123). INT MEDICAL PRESS LTD

Taylor, GM; Stewart, GR; Cooke, M; Chaplin, S; Ladva, S; Kirkup, J; ... Young, DB; + view all (2003) Koch’s Bacillus – A Look at the First Isolate of <i>M. tuberculosis</i> from a Modern Perspective. Microbiology , 149 (11) 3213 - 3220. 10.1099/mic.0.26654-0.

Taylor, S; Cane, P; Hue, S; Xu, L; Wrin, T; Hellmann, N; ... Pillay, D; + view all (2003) Identification of a transmission chain of HIV type 1 containing drug resistance-associated mutations. AIDS RES HUM RETROV , 19 (5) 353 - 361.

Taylor, S; Sadiq, ST; Weller, I; Kaye, S; Workman, J; Cane, PA; ... Pillay, D; + view all (2003) Drug-resistant HIV-1 in the semen of men receiving antiretroviral therapy with acute sexually transmitted infections. ANTIVIR THER , 8 (5) 479 - 483.

Temperton, NJ; Quenelle, DC; Lawson, KM; Zuckerman, J; N, K; E, G; ... V, C; + view all (2003) Enhancement of humoral immune responses to a human cytomegalovirus DNA vaccine: adjuvant effects of aluminium phosphate and CpG oligodeoxynucleotides (ODN). Journal of Medical Virology , 70 (1) 86 - 90.

Temperton, NJ; Quenelle, DC; Lawson, KM; Zuckerman, JN; Kern, ER; Griffiths, PD; Emery, VC; (2003) Enhancement of humoral immune responses to a human cytomegalovirus DNA vaccine: Adjuvant effects of aluminum phosphate and CpG oligodeoxynucleotides. J MED VIROL , 70 (1) 86 - 90. 10.1002/jmv.10357.

Thomas, ER; Shotton, C; Weiss, RA; Clapham, PR; McKnight, A; (2003) CD4-dependent and CD4-independent HIV-2: consequences for neutralization. AIDS , 17 (3) 291 - 300. 10.1097/01.aids.0000050804.28043.58.

Tormey, VJ; Buscombe, JR; Johnson, MA; Thomson, AP; Webster, AD; (2003) SPECT scans for monitoring response to pleconaril therapy in chronic enteroviral meningoencephalitis. Journal of Infection , 46 (2) 138 - 140.

Towers, GJ; Goff, SP; (2003) Post-entry restriction of retroviral infections. AIDS Rev , 5 (3) 156 - 164.

Towers, GJ; Hatziioannou, T; Cowan, S; Goff, SP; Luban, J; Bieniasz, PD; (2003) Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors. NAT MED , 9 (9) 1138 - 1143. 10.1038/nm910.

V

Van Herck, K; Zuckerman, J; Castelli, F; Van Damme, P; Walker, E; Steffen, R; (2003) Travelers' knowledge, attitudes, and practices on prevention of infectious diseases: results from a pilot study. Journal of Travel Medicine , 10 (2) 75 - 78.

Van Herck, K; Zuckerman, JN; Castelli, F; Van Damme, P; Walker, E; Steffen, R; (2003) Travellers' knowledge, attitudes and practices on prevention of infectious diseases - results from a pilot study. Journal of Travel Medicine , 10 75 - 78.

Vaughan, HE; Cane, P; Pillay, D; Tedder, RS; (2003) Characterization of HIV type 1 clades in the Caribbean using pol gene sequences. MARY ANN LIEBERT INC PUBL

Voisset, C; Myers, RE; Carne, A; Kellam, P; Griffiths, DJ; (2003) Rabbit endogenous retrovirus-H encodes a functional protease. Journal of General Virology , 84 (Pt 1) 215 - 225.

W

Wagenaar, TR; Grose, C; Loparev, VN; Schmid, DS; Breuer, J; (2003) Genomic analysis of varicella-zoster virus: primers for individual open reading frames. J CLIN VIROL , 28 (1) 104 - 110. 10.1016/s1386-6532(03)00073-8.

Walker, C; Sawicka, E; Rook, GA; (2003) Immunotherapy with mycobacteria. Curr Opin Allergy Clin Immunol , 3 (6) 481 - 486. 10.1097/01.all.0000104446.09202.3c.

Weiss, RA; (2003) Cross-species infections. Current Topics in Microbiology and Immunology , 278 48 - 71.

Weiss, RA; (2003) Cross-species infections. CURR TOP MICROBIOL , 278 47 - 71.

Weiss, RA; (2003) Family heirlooms and new acquisitions: the origins of human viruses. In: JOURNAL OF CLINICAL VIROLOGY. (pp. S24 - S24). ELSEVIER SCIENCE BV

Weiss, RA; (2003) HIV and AIDS in relation to other pandemics. EMBO Reports , 4 S10 - S14.

Weiss, RA; (2003) HIV and AIDS in relation to other pandemics - Among the viruses plaguing humans, HIV is a recent acquisition. Its outstanding success as an infection poses immense scientific challenges to human health and raises the question "What comes next?". EMBO REPORTS , 4 S10 - S14. 10.1038/sj.embor.embor857.

Weiss, RA; (2003) HIV and AIDS: looking ahead. NAT MED , 9 (7) 887 - 891.

Weiss, RA; (2003) Host genetic polymorphisms and HIV infection. In: JOURNAL OF CLINICAL VIROLOGY. (pp. S42 - S42). ELSEVIER SCIENCE BV

Weiss, RA; (2003) Response from Weiss: Evolution of virulence: adaptive or not? TRENDS MICROBIOL , 11 (3) 113 - 114. 10.1016/S0966-843X(03)00022-2.

Weiss, RA; (2003) Human receptors for retroviruses. In: Sugumura, K and Uchiyama, T and Matsuoka, M and Kannagi, M, (eds.) Gann Monograph on Cancer Research No 50: Two decades of adult T-cell leukaemia and HTLV-1 research. Japan Scientific Societies Press

Wilson, APR; (2003) Antibacterial prophylaxis in surgery. 1- Gastrointestinal and biliary surgery. Drug and Therapeutics Bulletin , 41 (11) 83 - 86.

Wilson, APR; (2003) Infections in Obstetrics. In: Williams, JD and Taylor, EW, (eds.) Infection in Surgical Practice. (271 - 280). Arnold: London.

Wilson, P; Andrews, JA; Charlesworth, R; Walesby, R; Singer, M; Farrell, DJ; Robbins, M; (2003) Linezolid resistance in clinical isolates of Staphylococcus aureus. Journal of Antimicrobial Chemotherapy , 51 (1) 186 - 188.

Z

Ziegler, J; Newton, R; Bourboulia, D; Casabonne, D; Beral, V; Mbidde, E; ... Boshoff, C; + view all (2003) Risk factors for Kaposi's sarcoma: A case-control study of HIV- seronegative people in Uganda. International Journal of Cancer , 103 (2) 233 - 240.

Zuckerman, J; West, D; Kassianos, G; (2003) "Dukoral": Cholera. CSF Medical Communications

Zuckerman, JN; (2003) 1. Vaccination priorities in travel. In: The Art of Travel Medicine. 2003; 17:1 – 6. BioDrugs , 17 1 - 6.

Zuckerman, JN; (2003) 1Avian influenza outbreak. Journal of Travel Medicine & Infectious Disease , 1 199 - 200.

Zuckerman, JN; (2003) Hepatitis E and the traveller. Travel Med Infect Dis , 1 (2) 73 - 76. 10.1016/S1477-8939(03)00039-5.

Zuckerman, JN; (2003) Introduction to the journal of travel medicine & infectious disease. Journal of Travel Medicine & Infectious Disease , 1 1 - 2.

Zuckerman, JN; (2003) Review and Recommendations to Seafarers on Immunisations and Prevention of Malaria including the use of Prophylaxis. Maritime & Coastguard Agency of the Department of Transport, United Kingdom.

Zuckerman, JN; (2003) The place of accelerated schedules for hepatitis A and B vaccinations. DRUGS , 63 (17) 1779 - 1784.

Zuckerman, JN; (2003) The traveller and West Nile virus. Travel Med Infect Dis , 1 (3) 149 - 152. 10.1016/S1477-8939(03)00064-4.

Zuckerman, JN; (2003) Vaccination priorities in travel. BIODRUGS , 17 1 - 6.

Zuckerman, JN; Nothdurft, HD; Dietrich, M; Knobloch, J; Kern, P; Sanger, R; (2003) Rapid protection against hepatitis A and B following an accelerated schedule of a combined hepatitis A/B vaccine. In: Margolis, H and Alter, M and Conlon, I and Dienstag, AL, (eds.) (Proceedings) Viral Hepatitis and Liver Disease; Proceedings of the 10th International Symposium on Viral Hepatitis and Liver Disease 2000. (pp. 60 - 62). International Medical Press Ltd: London.

Zuckerman, JN; Van Damme, P; Van Herck, K; Löscher, T; (2003) Vaccination options for last-minute travellers in need of travel-related prophylaxis against hepatitis A & B and typhoid fever: a practical guide. Journal of Travel Medicine & Infectious Disease , 1 219 - 226.

Zuckerman, JN; Zuckerman, AJ; (2003) Mutations of the surface protein of hepatitis B virus. ANTIVIRAL RESEARCH , 60 (2) 75 - 78. 10.1016/j.antiviral.2003.08.013.

Zuckerman, JN; Zuckerman, AJ; (2003) Hepatitis Viruses. In: Cohen, J and Powderly, WG, (eds.) Infectious Diseases. (2007 - 2021). Elsevier Science

Zuckerman, JN; Zuckerman, AJ; (2003) Viral Hepatitis. In: Cook, GC, (ed.) Manson's Tropical Diseases. (707 - 723). W.B. Saunders, Elsevier Science Ltd: Edinburgh.

Zuckerman, JN; Zuckerman, AJ; (2003) Prevention & treatment of viral hepatitis. In: Trafton, J and Gordon, W, (eds.) Best Practices in the Behavioural Management of Chronic Disease. Institute for Brain Potential

Zumla, A; Fortescue, S; (2003) BookPower. POSTGRAD MED J , 79 (938) 670 - 670.

Zumla, A; Gandy, M; (2003) Epilogue: Politics, science and the 'new' tuberculosis. In: Gandy, M and Zumla, A, (eds.) The return of the white plague: global poverty and the 'new' tuberculosis. (237 - 241).

Zumla, A; Sa'adu, A; Roitt, I; (2003) Immunological Aspects of Tropical Diseases. In: Cook, GC and Zumla, AI, (eds.) Manson's Tropical Diseases. (57 - 73). W.B. Saunders, Elsevier Science Ltd: Edinburgh.

Zumla, AI; (2003) Editorial overview: Infectious diseases. Curr Opin Pulm Med , 9 (3) 163 - 165.

Zumla, AI; (2003) Infectious diseases. Current Opinion in Pulmonary Medicine , 9 (3) 163 - 165. 10.1097/00063198-200305000-00001.

This list was generated on Sun Apr 13 12:35:57 2014 BST.